On 24 October 2023 the European Commission adopted a set of actions to better prevent and mitigate critical medicine shortages in the EU. Recent critical shortages, including of certain antibiotics last winter, show that continued coordinated action is needed to address supply challenges and to make Europe's medicine supply chains more resilient in the long run. The main objective of the Communication is to prevent and mitigate critical shortages at EU level, focusing in particular on the most critical medicines, for which security of supply in the EU must be ensured at all times.
EESC opinion: Communication on availability of medicines
The European Defence Investment Programme (EDIP) regulation will serve as the anchor for future joint development and procurement projects of high common interest to the security of the Member States and the Union.
In elaborazione (updated on 23/03/2024) - Bureau decision date: 24/10/2023
EDIS is a joint communication of the Commission and the High Representative that sets a vision for the European defence industrial policy until 2035.
The EESC welcomes this Commission initiative and the CCMI study group members will examine how the European Defence Industrial Strategy can strengthen the European Defence Technological and Industrial Base (EDTIB) and achieve defence industrial readiness. Furthermore, this opinion will assess the necessary steps for the successful implementation of this strategy.
In elaborazione (updated on 21/03/2024) - Bureau decision date: 16/01/2024
